Optimization of MRI for Radiation Therapy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02045381|
Recruitment Status : Suspended (Enrollment and/or interactions/interventions temporarily paused due to COVID-19 and expected to resume in the future. This is not a suspension of IRB approval.)
First Posted : January 24, 2014
Last Update Posted : June 4, 2020
|Condition or disease||Intervention/treatment|
|Cancer Liver Cancer Brain Cancer Head &Neck Cancer Pelvis||Procedure: MRI Group|
|Study Type :||Observational|
|Estimated Enrollment :||432 participants|
|Official Title:||Optimization of MRI for Radiation Therapy|
|Study Start Date :||February 2013|
|Estimated Primary Completion Date :||October 2020|
|Estimated Study Completion Date :||October 2021|
Patient receives one research MRI prior to radiation treatment.
Procedure: MRI Group
A single research MRI
- Percentage of participants with MRI images suitable for analyses [ Time Frame: Day One ]Patients will be off protocol immediately after the single MRI scan. Comparative treatment planning will occur off-line and will not be used for patient care.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02045381
|United States, Michigan|
|Univeristy of Michigan|
|Ann Arbor, Michigan, United States, 48109|
|Principal Investigator:||Shruti Jolly, MD||University of Michigan|